MERSANA THERAPEUTICS INC's ticker is MRSN and the CUSIP is 59045L106. A total of 129 filers reported holding MERSANA THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 4.48 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $102,000 | +78.9% | 15,156 | +6.1% | 0.00% | +100.0% |
| Q1 2022 | $57,000 | 0.0% | 14,280 | +55.7% | 0.00% | 0.0% |
| Q4 2021 | $57,000 | -52.5% | 9,173 | +3.6% | 0.00% | -50.0% |
| Q2 2021 | $120,000 | +166.7% | 8,853 | +218.9% | 0.00% | +100.0% |
| Q1 2021 | $45,000 | -67.6% | 2,776 | -53.3% | 0.00% | -86.7% |
| Q2 2020 | $139,000 | +6850.0% | 5,947 | +485.3% | 0.02% | +1400.0% |
| Q3 2019 | $2,000 | -50.0% | 1,016 | +43.5% | 0.00% | -50.0% |
| Q1 2019 | $4,000 | -66.7% | 708 | +3.7% | 0.00% | -50.0% |
| Q2 2018 | $12,000 | – | 683 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SILVERARC CAPITAL MANAGEMENT, LLC | 5,000,000 | $6,350,000 | 1.92% |
| VR Adviser, LLC | 11,328,000 | $14,386,560 | 1.51% |
| Bain Capital Life Sciences Investors, LLC | 8,663,673 | $11,002,865 | 1.23% |
| Affinity Asset Advisors, LLC | 2,850,000 | $3,619,500 | 1.02% |
| EcoR1 Capital, LLC | 19,364,688 | $24,593,154 | 0.83% |
| Altium Capital Management LP | 1,059,136 | $1,345,103 | 0.70% |
| 5AM Venture Management, LLC | 1,305,000 | $1,657,350 | 0.48% |
| Decheng Capital Management III (Cayman), LLC | 904,268 | $1,148,420 | 0.38% |
| COMMODORE CAPITAL LP | 2,244,378 | $2,850,360 | 0.33% |
| Philosophy Capital Management LLC | 2,342,634 | $2,975,145 | 0.32% |